Objectives: This meta-analysis evaluated the effects of exercise interventions on key health outcomes in adults with SLE, including fatigue, physical function, aerobic capacity, disease activity, depression and pain. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines, we systematically searched four databases up to February 2025 for randomised controlled trials (RCTs) in adults diagnosed with SLE according to the American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) criteria. Eligible studies examined aerobic, resistance or combined exercise as the sole intervention. Meta-analyses were conducted using Hedges’ g, the Risk of Bias 2 (ROB-2) tool and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system used to assess bias and evidence quality. Results: Twelve RCTs involving 470 participants were included. Exercise showed small-to-moderate improvements in fatigue (g=−0.53, 95% CI −0.81 to −0.25, p<0.001), physical function (g=0.46, 95% CI 0.23 to 0.68, p<0.001), aerobic capacity (g=0.47, 95% CI 0.22 to 0.71, p<0.001), depression (g=−0.36, 95% CI −0.64 to −0.09, p=0.01) and pain (g=−0.53, 95% CI −0.86 to −0.20, p<0.001), with no significant change in disease activity (g=0.18, 95% CI −0.16 to 0.51, p=0.30). Subgroup analyses suggested greater benefits with moderate-intensity programmes lasting 8–12 weeks. GRADE rated the evidence as moderate for fatigue, physical function, depression and pain, and low for other outcomes. Conclusion: Exercise is an effective non-pharmacological therapy in SLE management, improving several physical and psychological outcomes. Individualised, moderate-intensity and supervised programmes are recommended. Further research should optimise intervention protocols and evaluate long-term safety. PROSPERO registration number: CRD420251115953